No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs11082551 |
chr18:44291419-44291420 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs41471844 |
chr18:44291440-44291441 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
3 |
rs114889591 |
chr18:44291477-44291478 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs386802907 |
chr18:44291478-44291479 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs12605659 |
chr18:44291479-44291480 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs571627293 |
chr18:44291481-44291482 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs138732058 |
chr18:44291490-44291491 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs547858221 |
chr18:44291548-44291549 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs185169851 |
chr18:44291549-44291550 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs531864543 |
chr18:44291575-44291576 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs149297751 |
chr18:44291576-44291577 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs144572059 |
chr18:44291683-44291684 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs113122101 |
chr18:44291714-44291715 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs572454597 |
chr18:44291715-44291716 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs539823264 |
chr18:44291746-44291747 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs372836691 |
chr18:44291747-44291748 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs553523024 |
chr18:44291767-44291768 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs573645294 |
chr18:44291818-44291819 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs542378170 |
chr18:44291819-44291820 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs562653506 |
chr18:44291831-44291832 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs78863685 |
chr18:44291834-44291835 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs545263626 |
chr18:44291844-44291845 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs17778939 |
chr18:44291905-44291906 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs148452839 |
chr18:44291930-44291931 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs372829844 |
chr18:44291977-44291978 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs527934787 |
chr18:44291986-44291987 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs8099322 |
chr18:44292026-44292027 |
Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs567574418 |
chr18:44292068-44292069 |
Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs530162896 |
chr18:44292216-44292217 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs550016070 |
chr18:44292220-44292221 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs570172806 |
chr18:44292355-44292356 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs187994213 |
chr18:44292362-44292363 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs552384306 |
chr18:44292366-44292367 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs142581567 |
chr18:44292384-44292385 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs535000469 |
chr18:44292397-44292398 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs553698582 |
chr18:44292440-44292441 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs573557911 |
chr18:44292476-44292477 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs536302018 |
chr18:44292493-44292494 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs56190504 |
chr18:44292509-44292510 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs576251451 |
chr18:44292580-44292581 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs191519339 |
chr18:44292594-44292595 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs948570 |
chr18:44292598-44292599 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
43 |
rs183767336 |
chr18:44292609-44292610 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs540972472 |
chr18:44292647-44292648 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs756032 |
chr18:44292667-44292668 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs530033476 |
chr18:44292684-44292685 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs550199167 |
chr18:44292686-44292687 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs563422086 |
chr18:44292695-44292696 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs532505930 |
chr18:44292742-44292743 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs552320807 |
chr18:44292743-44292744 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|